Home › Infertility › NCT04472156

A Prospective Study of a Mosaic Embryo Transfer

Who can join

Ages 18 to 45 · Women · Healthy volunteers welcome

Inclusion Criteria:

* Women age 18-45 Infertile women who have completed an IVF cycle with PGT at the Colorado Center for Reproductive Medicine (CCRM) that have a mosaic embryo
* Patients can be of any race, culture, sexual orientation or ethnicity
* Patients that are willing to transfer a single embryo

Exclusion Criteria:

* Patients that do not meet the clinical requirements for an embryo transfer per clinic standards.
* Patients that desire more than a single embryo transfer.
* Patients that are using a gestational carrier.
* Embryonic mosaic PGT results that include chromosome errors 13, 18, 21
* Patients that did not complete their IVF with PGT cycle at the Colorado Center for Reproductive Medicine.

About the study

This research is a prospective study in which the purpose is to investigate the clinical outcomes following the transfer of a mosaic embryo (presence of both chromosomally normal and abnormal cells) that has been screened for preimplantation genetic testing (PGT).

What is being tested

• Transfer of mosaic embryo (procedure)

Sponsor: Colorado Center for Reproductive Medicine · Participants: 250 · Started: Oct 15, 2020

Contact the study team

• Rachel Makloski, RN · Phone: 303-788-8300

Official record on ClinicalTrials.gov — NCT04472156

Locations in the U.S.

Conditions

• Infertility

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.